Skip to main content

ALVO · Alvotech · Earnings Call Transcripts & Audio

Track ALVO — free
$5.80 -0.12 (-2.03%) At close · Sep 30
Market Cap
$2.19B
Shares
356.82M
Volume · Sep 30 1.14M Avg daily vol (3M) 984.23K

Alvotech Earnings Call Transcripts

Quarterly earnings calls for Alvotech (ALVO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q4
2027-03-11
Alvotech (ALVO) Q4 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-11-12
Alvotech (ALVO) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-20
Alvotech (ALVO) Q2 2026 Earnings Call Transcript
Positive tone Pipeline and upcoming submissions Guidance reaffirmation and quarterly cadence Manufacturing ramp-up after facility improvements
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Alvotech (ALVO) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-04
Alvotech (ALVO) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-19
Alvotech (ALVO) Q4 2025 Earnings Call Transcript
Positive tone Pipeline submissions and approvals FDA inspection and BLA resubmissions Geographic expansion
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Alvotech (ALVO) Q3 2025 Earnings Call Transcript
Positive tone FDA Complete Response Letter for Simponi biosimilar Biosimilar pipeline and development programs Reykjavik facility inspection and remediation
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Alvotech (ALVO) Q2 2025 Earnings Call Transcript
Confident tone Financial performance and growth Humira biosimilar (SIMLANDI/HUKYNDRA) STELARA biosimilar (AVT04)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Alvotech (ALVO) Q1 2025 Earnings Call Transcript
Confident tone Stelara biosimilar launch and interchangeable designation Humira / SIMLANDI commercial performance Capacity / manufacturing scale
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Alvotech (ALVO) Q3 2024 Earnings Call Transcript
Confident tone Pipeline Advancement 2025 Revenue Guidance FDA Inspection and Compliance
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Alvotech (ALVO) Q2 2024 Earnings Call Transcript
Confident tone US Humira (adalimumab) biosimilar ramp Pipeline expansion and upcoming submissions Stelara biosimilar (SELARSDI / AVT04)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Alvotech (ALVO) Q1 2024 Earnings Call Transcript
Confident tone Humira biosimilar (AVT02) U.S. launch Stelara biosimilar (AVT04/Selarsdi) global launches Pipeline expansion and new filings
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Alvotech (ALVO) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Alvotech (ALVO) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Alvotech (ALVO) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Alvotech (ALVO) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Alvotech (ALVO) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Alvotech (ALVO) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Alvotech (ALVO) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–19 of 19 earnings calls
Key facts CIK 1898416 CUSIP L01800108 13F (30d) 1 filings 1 filers Visit website Investor relations